Corvus Pharmaceuticals, Inc. (CRVS) Unrecognized Tax Benefits USD 2015 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of unrecognized tax benefits.
Summary: Corvus Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from 2015 to 2023.
Corvus Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $12.8 M, a 0.81% increase year-over-year.

Unrecognized Tax Benefits, Quarterly (USD)

Unrecognized Tax Benefits, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$12.8 M	+$103 K	+0.81%	Dec 31, 2023	10-K	2024-03-19
Q4 2022	$12.7 M	+$216 K	+1.73%	Dec 31, 2022	10-K	2024-03-19
Q4 2021	$12.5 M	+$347 K	+2.85%	Dec 31, 2021	10-K	2024-03-19
Q4 2020	$12.2 M	+$10.3 M	+545%	Dec 31, 2020	10-K	2024-03-19
Q4 2019	$1.89 M	+$81 K	+4.49%	Dec 31, 2019	10-K	2023-03-28
Q4 2018	$1.8 M	+$585 K	+48%	Dec 31, 2018	10-K	2022-03-10
Q4 2017	$1.22 M	+$615 K	+102%	Dec 31, 2017	10-K	2021-03-25
Q4 2016	$604 K	+$469 K	+347%	Dec 31, 2016	10-K	2020-03-09
Q4 2015	$135 K			Dec 31, 2015	10-K	2019-03-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.